Enterohemorrhagic Escherichia coli (EHEC), particularly serotype O157:H7, causes hemorrhagic colitis, hemolytic uremic syndrome, and even death. In vitro studies showed that Shiga toxin 2 (Stx2), the primary virulence factor expressed by EDL933 (an O157:H7 strain), is encoded by the 933W prophage. And the bacterial subpopulation in which the 933W prophage is induced is the producer of Stx2. Using the germ-free mouse, we show the essential role 933W induction plays in the virulence of EDL933 infection. An EDL933 derivative with a single mutation in its 933W prophage, resulting specifically in that phage being uninducible, colonizes the intestines, but fails to cause any of the pathological changes seen with the parent strain. Hence, induction of the 933W prophage is the primary event leading to disease from EDL933 infection. We constructed a derivative of EDL933, SIVET, with a biosensor that specifically measures induction of the 933W prophage. Using this biosensor to measure 933W induction in germ-free mice, we found an increase three logs greater than was expected from in vitro results. Since the induced population produces and releases Stx2, this result indicates that an activity in the intestine increases Stx2 production.
Infection with Enterohemorrhagic E. coli (EHEC), and more recently with the Enteroaggregative E. coli strain O104:H4, is a significant health risk, causing bloody diarrhea, kidney failure, and even death. The virulence factor in these bacteria responsible for the severe outcomes is Shiga toxin (Stx). Genes encoding Stx are in the genome of bacterial viruses (prophages) on the pathogenic E. coli chromosomes. The prophage remains quiescent until damage to the bacterial chromosome occurs causing prophage gene expression (called induction), which leads to production of bacteriophages that are released into the environment. Because stx expression is controlled by the phage regulatory system, prophage induction leads additionally to production and release of Stx. This study provides conclusive evidence that in a mouse model of EHEC infection, induction of the prophage carrying the stx genes is specifically required for EHEC to cause disease and that the intestinal environment adds to the induction and therefore to the production of Stx. Similar events likely regulate Stx production and release by the Stx encoding phage in the O104:H4 strain. Controlling prophage induction offers a means to control EHEC infection.
Citation: Tyler JS, Beeri K, Reynolds JL, Alteri CJ, Skinner KG, et al. (2013) Prophage Induction Is Enhanced and Required for Renal Disease and Lethality in an EHEC Mouse Model. PLoS Pathog 9(3): e1003236. doi:10.1371/journal.ppat.1003236
Editor: Ralph R. Isberg, Tufts University School of Medicine, United States of America
Received: November 16, 2012; Accepted: January 22, 2013; Published: March 28, 2013
Copyright: © 2013 Tyler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was provided by Public Health Service grant AI11459-10, the University of Michigan Endowment for the Basic Sciences, and the 599 NIAID, NIH, Department of Health and Human Services, under Contract No. N01-AI-30058 from the National Institutes of Health. JST was supported in part by NIH Training Grant GM008353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Enterohemorrhagic E. coli (EHEC) has emerged as a serious health threat with numerous outbreaks most commonly due to contaminated beef, but also to contaminated vegetables and water . Although EHEC strains , and another recently identified pathogenic E. coli , encode a number of virulence factors, the most serious sequelae of infection by these strains are due to the acquisition and expression of genes encoding Shiga toxins (Stx).
In many EHEC strains these toxins are encoded in the genomes of prophages of the λ family (referred to as lambdoid phage) . Two major classes of Shiga toxins, Stx1 and Stx2, have been identified in EHEC strains . Although sharing the same activity, they differ somewhat in sequence and Stx2 is associated with the more severe sequelae in humans  and is the cause of disease in animal models . These members of the AB5 class of toxins bind eukaryotic cells by attachment of the pentameric structure of the B subunit to a glycoprotein receptor on the eukaryotic cell . Retrograde transit through the endosomic pathway to the cytosol results in the A subunit, a glycosidase, reaching the ribosomal RNA . There, a specific adenine residue in the large ribosomal subunit is cleaved, resulting in arrested protein synthesis that leads to cellular intoxication . EHEC strains commonly isolated in outbreaks are those of the O157:H7 serotype .
Members of the lambdoid family of temperate phages share a common genome organization with prototypical λ. Genes at the same relative position on their respective genomes may differ in sequence, but for the most part they share the same activity . For example, the repressors and operators may differ in sequence and specificity, but the different lambdoid phages have a common structure and location for these genetic elements on their genomes . Moreover, the lambdoid phages are mosaics with each phage sharing a number of different genes with different members of the family , . These conserved structure-function relationships allowed for the relatively rapid determination of the role of the phage in Stx expression .
When present, the stxA and B genes are located downstream of PR′, the late phage promoter , , and upstream of the phage lysis genes (Fig. 1) , . In vitro and in vivo studies with the O157:H7 strain 1:361 and its resident stx2-phage, φ361, showed that transcription from PR′ is required for Stx2 production . In vitro studies with the E. coli strain K9675 (a derivative of the nonpathogenic strain K37 lysogenized with the stx2-phage 933W) showed that Stx2 expression requires prophage induction . Hence, Stx2 expression, at least under these in vitro conditions, depends on the phage induction cascade. Prophage induction explains why patient treatment with antibiotics that can act as inducing agents, such as the quinolones, lead to higher Stx levels  and exacerbate the disease .
Figure 1. Diagrams illustrating genetic arrangements and constructs.
I. The regulatory region of stx-carrying lambdoid phage and patterns of regulated transcription (not drawn to scale) (A) Arrangement of relevant genes. (B) Operators and promoters. (C) Transcription terminators. (D) Transcription patterns based on studies with λ. Temporal order: Early transcripts from PL and PR ending at indicator terminators, with ~40% transcending tR1. Action of antitermination protein N allows synthesis of delayed early transcripts. Action of antitermination protein Q immediately downstream of PR′ allows maximum synthesis of late transcripts that include the stx genes. II. Components of SIVET (not drawn to scale). Top: (E) The early regulatory region of the 933W SIVET prophage. Deletion substitutions, N::spc and O-P::amp eliminate lethality by the induced prophage. The tnpR gene encodes the γδ resolvase and is transcribed from the prophage PR promoter and under control of the 933W repressor. Hence, TnpR is not expressed by the repressed lysogen, but is expressed when induction leads to autocleavage of the phage repressor. Bottom: (F) SIVET reporter cassette with the cat gene interrupted with a kanR cassette flanked by resC sites (targets for TnpR resolvase). In this form the reporter cassette confers KanR. (G) Action of TnpR removes the kanR cassette and one flanking resC site. This leaves the cat gene interrupted by one resC site on the bacterial chromosome. By proper designing the position of the insertion site of the cassette in the cat gene of the reporter cassette as well as engineered small nucleotide changes in the res sequence, excision of the kanR cassette leaves a functional cat gene even though a resC sequence remains within the cat gene (confers CamR) . (H) The kanR cassette with the other resC site is excised as a non-replicating circle and lost by segregation. The thick horizontal arrows in E represent patterns of transcription from early promoters following induction, loss of repression.doi:10.1371/journal.ppat.1003236.g001
The lambdoid phage regulatory cascade which leads to phage production and cell lysis has been the subject of years of study with λ and to a lesser extent with other members of this family of phages . Induction, which results in the initiation of the regulatory cascade, is set in motion when the bacterium containing the prophage (lysogen) sustains DNA damage and responds by activation of the LexA regulon, leading to a cellular change in gene expression termed the SOS response , . One member of this regulon, RecA, increases in quantity and assumes an activated form, RecA*, by interacting with single-stranded DNA generated by DNA damage . RecA*, through its co-protease activity, facilitates the autocleavage of phage repressor , allowing initiation of transcription from the early PL and PR promoters (Fig. 1). Transcription from PL results in expression of N protein, which acts to modify RNA polymerase initiating specifically at PL and PR to a form resistant to downstream terminators . N-modified transcription from PR transcends downstream terminators resulting in Q expression. Q in turn modifies transcription initiating at the late PR′ promoter to a termination-resistant form allowing expression of downstream genes , including stx A and B in stx-phages , , , .
A λ prophage fails to induce if the repressor gene (cI) has a mutation that inhibits autocleavage , . These mutations, called ind, change amino acid residues within the repressor that participate in a serine protease activity that catalyzes autocleavage .
We have previously suggested that the induced subpopulation is responsible for Stx production and release . Lysogens with most lambdoid prophages are stable with only an extremely small fraction of the population, in the absence of an external inducing agent, sustaining sufficient DNA damage to be induced, a stochastic process referred to as “spontaneous induction” . It has been suggested that collapse of the replisome in normally growing bacteria caused by single-stranded breaks or noncoding lesions may be an internal event responsible for spontaneous induction . DNA damage-inducing agents change induction from a stochastic to a deterministic process that activates RecA and, in turn, repressor cleavage . Although recA mutants have been used to study conditions where the prophage fails to be induced and Stx is not expressed , such an experimental approach suffers from the disadvantage of the pleiotropic effects on bacterial physiology due to loss of RecA activity , . Using a phage with an ind mutation avoids this problem by limiting the failure of SOS control only to the prophage with the ind mutation.
Linkage of Stx expression to prophage induction raises the question as to whether the intestinal environment increases Stx levels by causing prophage induction. One way this could occur would be by increasing DNA damage in the bacterium. In vitro experiments showed a modest increase in Stx production by an O157:H7 strain when bacteria were cultured with neutrophils , which produce H2O2 that can cause DNA damage leading to an SOS response and prophage induction.
Here, we report experiments with the O157:H7 strain EDL933 and derivatives of EDL933 that carry a 933W prophage with a cI ind mutation. Using a germ-free mouse model of disease, we show that whereas the parent EDL933 with wild-type 933W prophage produces high levels of Stx in vivo and causes severe disease that can lead to death, a derivative isogenic except for a cI ind mutation in the 933W prophage produces extremely low levels of Stx2 and does not cause any observable disease. These results provide compelling evidence that induction of the 933W prophage is a major factor in pathogenesis of EDL933 and prophage induction may play a role in the severity of infection by other O157:H7 strains. Using an EDL933 SIVET reporter strain, which survives induction but undergoes a change in antibiotic resistances following induction, we show that the intestinal environment contributes to induction of the 933W prophage in EDL933.
Characterization of the 933W ind mutant in EDL933
Induction of lambdoid prophages, including that of 933W, occurs when the repressor protein autocleaves in the presence of activated RecA protein . Mutations, ind, in the cI gene result in a noncleavable repressor and thus an uninducible prophage . The strategy used to obtain the ind mutation in the cI gene of the 933W prophage in EDL933, a change of Lys codon 178 [suggested by John Little ], was based in part on the procedure previously employed by our laboratory to construct an identical point mutation in the cI gene of the 933W prophage in strain K9675 . Sequencing confirmed that the cI gene in EDL933 with the mutant 933W had only the designed nucleotide substitution at codon 178. The mutation, named ind1, is a change of the Lys codon to an Asn codon (K178N). This change interferes with the autocatalytic serine protease activity of the CI repressor , rendering the prophage uninducible. We will refer to the derivative of EDL933 carrying the 933W prophage with the cIind1 mutation as EDL933cIind1 (Table 1). This strain carries the stx2 genes and differs from EDL933 only by the 933W cI mutation.
Table 1. Strain and plasmid list.doi:10.1371/journal.ppat.1003236.t001
To assess the effectiveness of the ind1 mutation on prophage induction, we treated EDL933 and EDL933cIind1 with mitomycin C . At an appropriate concentration, this DNA damaging agent activates the SOS response of most of the population sufficiently to induce the prophage . Treatment of the EDL933 parent with 2 µg/ml of mitomycin C led to full induction of the culture; i.e., lysis was nearly complete (Fig. 2). Identical treatment of EDL933cIind1 failed to cause lysis (Fig. 2). This result confirms that the ind1 mutation blocks induction of 933W. Additionally, it shows that the inducing agent does not cause any of the large number of defective prophage in EDL933  to express lytic activity. This finding provides direct evidence that induction of 933W is not only responsible for Stx2 production, as shown below, but also for the lysis that releases Stx2 from the bacterium.
Figure 2. Induction and lysis following mytomycin C treatment.
Aliquots of EDL933 and the cIind1 derivative untreated and treated with 2 µg/ml of mitomycin C were incubated with shaking at 37°. Ind: (+) EDL933, inducible, (−) EDL933cIind1 (K11349), not inducible. Mitomycin C: (+) treated, (−) untreated. Vertical arrow indicates time mitomycin C added.doi:10.1371/journal.ppat.1003236.g002
Shiga toxin production
We used an ELISA to assess Stx2A levels; comparing levels in EDL933 with those in the EDL933cIind1 derivative and the nonpathogenic 933W lysogen K9675. In the absence of an inducing agent, the parent EDL933 expresses ~40 times the level of Stx2 expressed by EDL933 cIind1 mutation (Fig. 3). This result provides compelling evidence that in culture a significant fraction of Stx2 production derives from the subpopulation of EDL933 in which the 933W prophage is induced. These results are only partially consistent with our previous findings with strain K9675 . In that study we found that in the absence of an external inducing agent, the level of Stx2A produced by K9675 was ~10 fold lower than the level produced under these conditions by EDL933 with its wild-type 933W prophage. In the current study, we confirmed these findings, showing that in the absence of an external inducer (spontaneous induction) EDL933 produces ~10 times more Stx2A than K9675 (Fig. 3).
Figure 3. Expression of Stx.
Levels of Stx were determined as outlined in Materials and Methods. Mitomycin C was used at a concentration of 2 µg/ml. Strains: EDL933, EDL933cIind1 (K11349), and K37-933W (K9675). Error bars indicate standard deviations. P values (mc = mitomycin C treated): (1) EDL933×EDL933 (mc) = 6.6×10−7; (2) EDL933×K11349 = 0.0056; (3) K11349×K11349 (mc) = 0.018; (4) EDL933×K9675 = 0.0069; (5) K9675×K9675 (mc) = 3.5×10−6; (6) EDL933 (mc)×K9675 (mc) = 0.00044.doi:10.1371/journal.ppat.1003236.g003
To rule out the possibility that the low Stx2A levels in the nonpathogenic strain resulted from alteration of the prophage or the host, we measured Stx2A production from another nonpathogenic K12 related strain, MC1000 , with a 933W prophage. As above, we observed the lower level of Stx2A expression in the non-pathogenic strain compared to EDL933 (data not shown). Although comparison of spontaneous induction shows that EDL933 produces ~10 fold higher levels of Stx2A than K9675, the source of Stx2A for each is primarily that fraction of the population in which the prophage is induced (this study and Tyler et al. .
Prophage induction and Stx2 production
To specifically assess the role of induction of the 933W prophage in Stx2 production, we determined Stx2 levels following treatment with mitomycin C (2 µg/ml). As shown in Fig. 3, mitomycin C treatment resulted in a 100 to 200-fold increase in Stx2 production by EDL933. Although K9675 produced significantly less Stx2 than EDL933 in the absence of an inducing agent, it produced about the same levels of Stx2 following treatment with mitomycin C as similarly treated EDL933.
The EDL933cIind1culture treated with mitomycin C produced 5- to 10-fold more Stx2 than the untreated culture. Although two orders of magnitude lower than the Stx2 production reached by EDL933 treated with mitomycin C, the increased levels we observed with the treated EDL933cIind1 were reproducible. The increase in Stx2 following mitomycin C treatment is consistent with the observation of measurable levels of Stx2 produced by EDL933cIind in the absence of an inducing agent. Either the mutant repressor retains some ability to autocleave (leaky mutant) in the EDL933 environment or there is an alternative route to Stx2 expression. However, in either event the production of Stx2 is extremely low in the presence of the cIind1 mutation.
Prophage induction and EDL933 pathogenicity
Results of clinical studies of children with EHEC infection show that phage induction likely plays an important role in the disease; e.g., those treated with antibiotics that elicit an SOS response may experience more severe outcomes . In mice, treatment with ciprofloxacin (an antibiotic that elicits the SOS response) also results in greater in vivo expression of Stx, likely via prophage induction .
Although suggestive, these findings are far from definitive. As discussed, the SOS response has pleiotropic effects on bacterial gene expression and does far more to affect cell physiology than induce prophage , . Relevant to our studies, treatment of EDL933 with the DNA damaging agent norfloxacin results in changes in the expression of a number of prophage and non-prophage genes in EDL933 . Because the only effect of the ind1 mutation is to interfere with induction of the 933W prophage, experiments with EDL933cIind1 allowed us to ask specifically how significant induction of the 933W prophage is in causing the pathology associated with EDL933 infection.
The germ-free mouse has proven an effective and practical animal model for studying the pathology of EHEC infection . We found that germ free mice infected with O157:H7 strains such as EDL933 develop acute renal tubular necrosis and renal glomerular thrombosis leading to renal failure and death. In the same study, we also reported that a similar infection with a derivative of EDL933 isogenic except for a deletion of the stx2 genes does not result in any of the pathogical changes seen with the wild-type parent strain. Hence, in this animal model, all of the described pathological changes result from the action of Stx2. For these reasons, we chose the germ-free mouse to assess the role in the disease process of induction specifically of the 933W prophage carried by EDL933. Groups of 6 (3 female and 3 male) germ-free Swiss-Webster mice were used in the experiments. They were infected with one of three bacteria, EDL933 or either of two isogenic strains that differed by having the Δstx::cat deletion substitution or the cIind1 point mutation. For all strains tested, each animal was challenged with 106 cfu administered orally. All three groups of mice were equally colonized over the seven days of the experiment in which bacteria in the feces were measured (~1010 cfu/g). As expected from our previous work, all 6 mice infected with the wild-type EDL933 parent strain became moribund prior to the scheduled time mice were euthanized at three weeks. All mice infected with the Δstx::cat deletion derivative showed no signs of disease. Like the latter group, mice infected with EDL933cIind1 showed no signs of disease (Fig. 4).
Figure 4. Disease in mice infected with EDL933.
A: Kaplan-Meier survival curve; B: Acute tubular necrosis score; C: Body weight at necropsy; D: Urine specific gravity; E: Hematoxylin and Eosin stained section of kidney from a mouse inoculated with EDL933. Many tubules are necrotic and contain cellular debris (arrows). A few glomeruli contain fibrin thrombi (arrowheads). F. Mouse infected with the EDL933cIind1 negative mutant. Tubules and glomeruli are normal. Bars = 50 microns. * Significantly different from mice infected with Ind- or Stx- mutants, p<0.001. Slides were scored blind without knowledge of their source. Animals were euthanized and tissues removed for examination; at 10 days post infection with EDL933 (day at which they became moribund) and at 21 days post infection with EDL933cIind1I (did not become moribund).doi:10.1371/journal.ppat.1003236.g004
Figure 4A shows a Kaplan-Meier survival curve of mice inoculated with the three strains. All 6 mice given EDL933 became moribund or died prior to 21 days after inoculation. At necropsy, these mice were dehydrated and thin, and their ceca were distended with fluid contents. Mice in this group had moderate-severe acute renal tubular necrosis (Fig. 4B), failed to gain weight as indicated by significantly lower body weights at necropsy (Fig. 4C), and all and dilute urine (Fig. 4D), indicating renal failure. Histologically, renal disease was characterized by necrosis of renal tubules and occasional glomerular fibrin thrombi (Fig. 4E). Mice in the other two groups did not show any signs of disease, and had normal renal morphology Fig. 4F). As noted above, cecal colonization was similar in all three groups of mice ruling out poor colonization as an explanation for the failure of EDL933cIind1 to cause disease.
As discussed, in vitro EDL933cIind1produces measurable levels of Stx2, raising the question of whether it produces measurable levels of Stx2 in the infected mouse. Although there was wide variation, we found low but measurable levels of Stx2 in the feces of some of the mice infected with EDL933cIind1, 0–300 ng/ml of feces. Much higher levels of Stx2, with considerable variation, were found in the feces of mice infected with EDL933, 6529±4432 ng/ml of feces (P = 0.0039).
Effect of in vivo environment on prophage induction
Based on the RIVET (recombinase based in vivo expression technology) , , we developed SIVET (selectable in vivo expression technology), with the aim of determining if there is any effect on prophage induction when bacteria are in the intestine. Studies with the first generation SIVET, constructed in the nonpathogenic E. coli strain MC1000, established this reporter system as a valid method for measuring prophage induction . Here we report construction of a second generation SIVET through modification of EDL933 (see Materials and Methods for details). Figure 1-II outlines the essential features of the SIVET system. Briefly, the 933W and 933V prophages in EDL933 were genetically altered so that functions lethal to the bacterial host  are not expressed upon induction and the bacterium therefore survives challenge with an inducing agent. The tnpR gene from the γδ transposon  was cloned downstream of the 933W early PR promoter distal to the cro gene. Thus, following induction of the 933W prophage transcription initiating at the phage promoter PR results in production of the TnpR resolvase that, in turn, acts at another site on the bacterial chromosome to excise a kanR cassette that interrupts a cat gene. This recombination serves two purposes, establishes a functional cat gene and removes the kanR cassette, conferring CamR. Hence, upon induction of the altered 933W prophage there is an irreversible and inheritable change of the host bacterium from KanR/CamS to KanS/CamR. The fraction of the total bacterial count that is CamR provides a measurement of the number of bacteria in which the prophage was induced.
That this change is due to prophage induction is shown by the results of the following experiments. First, treatment of the SIVET strain with mitomycin C, known to cause prophage induction , results in an increase of ~1000 fold in CamR colonies and a reduction of ~1000 fold of KanR colonies (Fig. 5). Second, treatment of a cIind1 mutant derivative of the SIVET strain (K11607) under exactly the same conditions used with the SIVET parent failed to cause any measurable change in the levels of KanR or CamR bacteria (Fig. 5).
Figure 5. SIVET induction by treatment with mitomycin C.
SIVET strains EDL933 (K11604) and EDL933cIind1 (K11607) were treated as described in the Materials and Methods. Bars show colony forming units with and without mitomycin C treatment; Left (ind+) EDL933 and right (ind−) EDL933cIind1. Error bars represent standard error of the mean.doi:10.1371/journal.ppat.1003236.g005
In the following in vitro and in vivo experiments, the ratio of CamR/KanR SIVET was standardized to simplify the presentation using what will be referred to as the “Induction Index”. This function is calculated as the log10 of (CamR/KanR output)/(CamR/KanR input) (for details see Materials and Methods). Because of the way the Induction Index is calculated, the starting point in the graphs, the input, is equal to log10 (1) or 0. This allows changes in induction to be monitored by observing movement of the Index away from 0.
The only way we see the ratio deviate, beyond expected scatter, from 0 on the Induction Index, is if one of the two populations increases more than the other either by a growth advantage or by addition of newly generated derivatives. To rule out alteration in the induction index due to a growth advantage of one or the other marked strain, we used two SIVET derivatives; one, K11607, locked in the KanR form by virtue of the cIind1mutation and the other, K11608, a derivative of K11607 which is isogenic except for the excision of the KanR cassette and thus is locked in the CamR form. The CamR/KanR ratio (calculated employing the formula used to generate the Induction Index) following coinfection with the locked in CamR and KanR derivatives hovers around 0 (Fig. 6A). Since there is no growth advantage to either form, any positive increase in the CamR/KanR Induction Index of the parental SIVET would have to be explained as addition by conversion from the KanR population to the CamR population, a direct consequence of induction of the 933W prophage in the KanR bacteria.
Figure 6. Measurement of in vitro prophage induction.
SIVET strains were grown in LB broth and serially diluted into fresh LB. Cultures were grown to desired densities and concentrations of CamR and KanR bacteria in cultures measured at indicated points in growth cycle. Multiple rounds of dilutions and growth allowed for indicated rounds of duplication. Where appropriate, low dilutions ensured that any CamR bacteria would be carried over during dilutions. Graphs show ratios of CamR/KanR on a log scale (calculated using the Induction Index formula) over the indicated number of generations. A. SIVET cIind1strains K11607 (locked in KanR form) and K11608 (CamR) were grown together in LB to stationary phase at which time bacterial counts were determined and dilutions were made for next round of growth. Error bars represent standard error of the mean. B. Cultures of K11604 were grown to stationary phase at which time bacterial counts were determined and dilutions were made for next round of growth. C. Cultures of K11604 were grown to late log phase at which time dilutions were made for next round of growth. Aliquots were removed at mid-log phase for determination of bacterial counts.doi:10.1371/journal.ppat.1003236.g006
As discussed above, a small fraction of a population of lysogens growing in the absence of an added inducing agent undergo induction, a process called spontaneous induction . To determine whether spontaneous induction of the SIVET prophage adds to the population of CamR bacteria, we measured the CamR/KanR ratio, determined as the Induction Index, over the course of a large number of doublings in vitro in two different ways (Fig. 6). In both approaches, the SIVET strain was serially passaged in vitro for a number of generations in LB medium and the CamR and KanR populations periodically measured by viable counts. In one set of experiments, the SIVET bacteria were grown to stationary phase and diluted 10-fold for the next passage (Fig. 6B) while in the other, the bacteria were kept in log phase and diluted from an OD600 of ~1.0 to an OD600 of 0.1 for the next passage (Fig. 6C). Both protocols yielded similar experimental results; the Induction Index remained relatively constant over many doublings, hovering around 0. These results lead us to conclude that spontaneous induction does not significantly affect the CamR/KanR ratio. We consider these results further in the Discussion.
Induction in the mouse intestine
To determine if the intestine environment contributes to prophage induction and thus Stx production, we employed the ELD933 SIVET strain using the infection protocol as described above. Each mouse was orally infected with ~106 SIVET bacterium. Because the 933W prophage was mutationally disarmed (see Materials and Methods for details) and thus does not produce Stx2, as expected, mice infected with EDL933 SIVET did not show signs of disease. Feces were isolated each day for seven days and bacterial counts were determined by plating on LB agar plates containing kanamycin or chloramphenicol. The total EDL933 SIVET count remained relatively constant over the course of the experiment, ~108 CFU/g of feces, although slightly decreasing by the seventh day (data not shown). The Induction Indexes over the 7 days presented in Fig. 7 were compiled from results of three independent experiments, each comprised of five mice.
Figure 7. Measurement of in vivo prophage induction.
Germ-free mice were infected with 106 bacteria. At the indicated times feces were collected, suspended in diluent, and dilutions plated on LB plates, with kanamycin (30 µg/ml), or chloramphenicol (9–10 µg/ml). Graphs show ratios of CamR/KanR on a log scale (calculated using the Induction Index formula) over the indicated number of days. (•) SIVET strain K11604. (○) K11604 derivatives with 933W cIind mutation; K11607 (locked in KanR) and K11608 (CamR) were co-inoculated. Error bars represent standard error of the mean.doi:10.1371/journal.ppat.1003236.g007
By day seven the Induction Index has increased by over three logs. The study was terminated at day 7, when the onset of severe disease caused by EDL933 usually occurs .
To determine if the change in the CamR/KanR Induction Index during in vivo growth of SIVET reflects a difference in viability of the two forms of the SIVET, we employed the SIVET pair K11607 and K11608. These derivatives, as discussed above, are locked in either the KanR or CamR form. Mice were co-infected with K11607 and K11608 and followed essentially as described for the in vivo SIVET study outlined above. Examination of fecal samples showed that the ratio of CamR/KanR (calculated using Induction Index formula) did not significantly change over the course of 7 days (Fig. 7); i.e., neither form of SIVET has a growth advantage during in vivo growth. Hence, the null hypothesis stands and we conclude that the increase of the CamR/KanR Induction Index observed during growth in the mouse intestine results from prophage induction.
Based on this collection of data, we conclude that there is significant induction of the 933W prophage in the germ free mouse intestine. Since Stx2 production is directly linked to 933W induction, it follows that the intestine, through action of a yet to be identified factor(s), stimulates Stx2 production through induction of the 933W prophage.
With the information gained from sequencing numerous bacterial genomes, it has become apparent that virulence factors are commonly located in genomes of prophage , . Introduction of a new function, such as a virulence factor, to a bacterium by a prophage is referred to as lysogenic conversion. Although Stx2 is an example of a phage-encoded toxin whose expression is controlled by the phage regulatory cascade, many other phage-encoded toxins are expressed independently of prophage regulatory functions. This is true for the classic toxin of Corynebacterium diphtheriae  and of cholerae toxin (CTX), which is encoded in the genome of the CTXΦ prophage . Expression of CTX is controlled by a complex circuitry of proteins encoded by regulatory genes located outside of the prophage genome . Observations like these led to the idea that phage, like other mobile elements, serve as agents that can transfer genetic information from one bacterium to another . However, at least in the case of stx-phages, the phage serves a wider role, not only being the source of transfer, but also the regulator of expression from the transferred virulence gene .
The construction of a derivative of EDL933 with the ind1 mutation in the 933W prophage coupled with an animal model that mimics, to a large degree, the human disease, has allowed us to specifically assess the contribution of induction of the 933W prophage to the disease process. Like its EDL933 parent, EDL933cIind1 effectively colonizes the host intestines. However, unlike the parental strain, the ind1 strain fails to elicit any of the hallmarks of an EHEC infection; e.g., physical signs of illness, renal disease, and death. That EDL933cIind1 colonizes the host intestine is consistent with our previously reported findings showing that a derivative of EDL933 with a deletion-substitution of the stx2 genes colonized as well as the parent strain with a functional stx2 gene . This observation is contrary to the findings of Robinson et al. , who reported that colonization was reduced if the O157:H7 strain did not express Stx2. As we have suggested previously , this difference may reflect our use of germ-free mice, while Robinson et al. used mice with normal microbiota.
Our results provide evidence that the major pathogenic effect of EDL933 results from induction of the 933W prophage. Hence, the phage regulatory cascade plays a central role in the pathogenesis of this O157:H7 strain and likely many others. Since repressor auto-cleavage requires activated RecA protein, which, in turn, is a product of the SOS response, it is primarily that subpopulation of bacteria, with a sufficiently vigorous SOS response that induces the 933W prophage and results in the production and release of Stx2.
Our observation that Stx2 production and disease in the mouse are directly related to induction of the 933W prophage raises the question as to whether there is a factor(s) in the intestines that increases the SOS response resulting in increased prophage induction beyond that expected from results of in vitro experiments. Such a role was found for a factor in human pharyngeal cells that induces a group A Streptococcus prophage . And a small but significant level of induction of Stx was observed when an EHEC strain was co-cultured with human neutrophils . In a similar manner, a factor(s) in the intestines that induces an SOS response might increase the levels of Stx produced by a population of infecting EHEC. Such a factor(s) could be a product of the host (e.g., neutrophils). Not considered here is the possible importance of the interaction between the microbiota and the mammalian intestine in the SOS response and resulting Stx2 production . Our studies with germ free mice show that even in the absence of the normal microbiota there is sufficient prophage induction to produce and release levels of Stx capable of causing renal disease and death.
Constructed regulatory networks as biosensors have wide biological applications . The studies reported here demonstrate the utility of the comparatively simple SIVET regulatory network as a tool for identifying conditions where prophage induction is enhanced. First, treatment in vitro of SIVET with the inducing agent mitomycin C results in overwhelming conversion of KanR to CamR (Fig. 5), confirming that SIVET responds to inducing agents as designed. Second, the experiments with the 933W cIind SIVET derivatives showed that the increase in CamR relative to KanR colonies observed during in vitro and in vivo growth is not due to a growth advantage of the CamR variants (Figs. 6 and 7). Third, no significant change in the ratio of CamR to KanR was observed over a large number of doublings during continuous in vitro growth of SIVET in the absence of an inducing agent (Fig. 6). This observation held true whether cultures prior to dilution were allowed to grow to stationary phase or were maintained in log phase. In each case dilutions were at a sufficiently high level to ensure that CamR bacteria were carried over during each dilution. It might be expected that CamR bacteria contributed de novo by induction should add to the growing population, resulting in an increase in the CamR/KanR ratio. However, the in vitro experiments failed to show an increase in the Induction Index over a large number of doublings (we discuss this apparent paradoxical finding in detail below). Based on these results, we conclude that spontaneous induction (induction in the absence of a known inducing agent) of the 933W prophage fails to lead to a measurable increase in conversion of SIVET from KanR to CamR. Hence, SIVET is not sufficiently sensitive to distinguish no induction from low levels of induction.
By eliminating obvious alternative explanations and showing that mitomycin C treatment results in an increase in the SIVET CamR/KanR ratio, these results confirm that SIVET can be used to identify the presence of inducing agents. Moreover, the failure to observe changes in the Induction Index over many rounds of doubling during in vitro growth, in the absence of an extrinsic inducing agent, indicates that even small measurable increases in the Induction Index should provide evidence of an extrinsic inducing agent.
In the light of this background information, the >3 log increase in the Induction Index observed in SIVET isolated from feces (Fig. 7) over the seven days following the initial infection provides evidence for action of an inducing factor in the mouse intestinal tract. We suggest three alternative, but not mutually exclusive, scenarios to explain this increase in the rate of induction: 1) a substantial portion of the bacteria reach a section of the intestinal tract that contains resident inducing activity; 2) the infection causes an increase in the amount and/or activity of a resident inducing activity; or 3) infection attracts an inducing activity or a cell (e.g., neutrophils) producing an activity. Since Stx2 production, in large measure, is directly related to phage induction (Fig. 3), the intestinal environment likely contributes to the severity of the EHEC infection.
Although we failed to observe any significant change in the Induction Index over many generations of in vitro growth, an increase in the Induction Index over time might be expected because spontaneous prophage induction  should result in TnpR expression and, at some level, conversion of KanR to CamR bacteria. This, in turn, would add to the total of CamR population over the number produced by replication of preexisting CamR population resulting in an increase in the CamR/KanR ratio.
We used mathematical modeling to gain a quantitative understanding of what the expected Induction Index over time would look like if all of the spontaneously induced KanR bacteria were able to contribute immediately to the CamR bacterial population. Based on a starting Induction Index of 0, the model adds the newly produced CamR bacterium at each division to the growing preexisting CamR population, predicting an increase in the Induction Index over time as shown in Fig. S1. If we assume a doubling every hour over the seven days of in vivo growth, the model predicts the Induction Index would increase a little over one log and, even assuming a doubling time of 20 minutes, the Index would increase by slightly over two logs, both substantially less than the over three logs observed in the in vivo SIVET experiment.
The counterbalancing actions that we see as potentially reducing the contribution of spontaneous induction might make to the CamR population, include: 1) as discussed above, SIVET may not be sufficiently sensitive to distinguish no induction from low induction; 2) there may be a delay in initiation of growth following recovery from the consequences of DNA damage that caused the induction , ; i.e., a phenotypic lag (graphed in Fig. S1); 3) removal of the KanR cassette may occur in only one of the multiple bacterial chromosomes  resulting in segregation of both CamR and KanR derivatives from a single induced KanR bacterium and thus resulting in no change in the CamR/KanR ratio ; and 4) there may be sufficient DNA damage in some of the bacteria to block further growth, compromising survival of those bacteria. This subpopulation would be part of the induced pool that although theoretically adding to the CamR population would not be alive to do so. Although collectively these actions could explain our results, we are far from having a definitive answer as to how the Induction Index maintains this steady state. Nor can we explain how the ratio of CamR/KanR colonies reaches a steady state that is maintained for many generations. However, failure of SIVET to identify low level induction (spontaneous), but identify high level induction, as with mitomycin C, indicates measurements by SIVET are likely to be an under representation.
Materials and Methods
All animal protocols were approved by the University Committee on Use and Care of Animals at the University of Michigan Medical School. The University of Michigan is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC, Intl) and the animal care and use program conforms to the standards of “The Guide for the Care and Use of Laboratory Animals” (published by the NRC).
Bacteria, phage, and plasmids
See Table 1.
Primers and oligonucleotides
See Table 2.
Table 2. Primers and oligonucleotides.doi:10.1371/journal.ppat.1003236.t002
LB, 10 g tryptone, 5 g yeast extract, 5 g NaCl/liter of H2O. For LB plates 10 g of agar was included. LB sucrose plates are LB plates without NaCl and made 10% in sucrose. Antibiotics were added at the following concentrations; spectinomycin 80 µg/ml, ampicillin 100 µg/ml (plasmids) 25 µg/ml (chromosomal), kanamycin 30 µg/ml, hygromycin 200 µg/ml, and chloramphenicol 9–10 µg/ml. TB plates, 10 g tryptone, 2.5 g NaCl, and 10 g agar/liter of H2O.
All of our constructs were engineered using the λ Red recombination system, colloquially referred to as recombineering . The λ Red functions were supplied in either of two ways: transiently by a heat pulse freeing a λ promoter on a truncated λ prophage from control by a Ts repressor (cI857) so that the downstream red genes could be transcribed, using DY378  or from pKD46 and derivatives of that plasmid carrying cloned λ red genes by adding arabinose to the growth medium to activate an Ara-regulated promoter . Single-stranded oligonucleotides or double-stranded PCR products of varying lengths having ~40 nucleotides of flanking sequences with homologies to the target regions were introduced by electroporation into bacteria expressing λ Red functions. The expressed Red functions recombine the introduced DNAs with the target site. In the absence of a selectable marker, a two-step procedure was used: a cat-sacB (CSB) cassette  was inserted by recombineering and the recombinant selected by resistance to chloramphenicol. This cassette was then exchanged by recombineering with the designed DNA product using as selection resistance to sucrose and confirming by screening for CamS. DNA sequencing by the University of Michigan Sequencing Core Facility confirmed structure of constructs.
Construction of EDL933 with a 933W ind1 prophage
Recombineering was used to cross the designed mutation from a single stranded oligonucleotide to the chromosome of strain K10985. The oligonucleotide contained a single nucleotide change that resulted in a replacement of Lys codon 178 (AAG) with an Asn codon (AAC). The following is the sequence of the DNA oligonucleotide (oligo #2) with the mutant nucleotide capitalized: 5′-ccgggtgatgaggtgtttgtcagaaccgttgaaggacacaacatgattaaCgttcttggctatgacagagatggagaataccaatttacaagcattaacca-3′. The pairing of the oligonucleotide with its complementary chromosomal DNA strand forms a C-C mismatch at the position of the nucleotide change. This mispairing is not repaired by the mismatch repair system . In the absence of mismatch repair there is a significant increase in isolation of bacteria with the designed nucleotide change . K10985, an EDL933 derivative with the pKD46 plasmid , was prepared for electroporation essentially as described by Murphy and Campellone . Following electroporation, bacteria were resuspended in 10 ml of LB broth and grown at 37°. After ~5 hrs of growth, dilutions of the bacteria were placed on LB plates and incubated overnight at 37°. The following day colonies were picked and stabbed to an LB plate and a TB plate that was layered with a lawn of K37, a strain that supports growth of 933W. Plates were incubated at 37° for two hours and the seeded plate was UV irradiated (1.6 Joules/M2/S for 30 seconds). Following overnight incubation at 37°, a zone of lysis in the lawn showed phage had been synthesized by an induced prophage. Two clones out of 160 tested showed no zones of lysis. These derivatives failed to lyse following treatment with mitomycin C and subsequent DNA sequencing showed that although they both had the cIind mutation, only one, EDL933cIind1, had no other changes and was selected for further study.
A similar strategy was used to construct an EDL933 SIVET ind mutant, K11607, that was KanR. A CamR derivative, K11608, isogenic except for the loss of the KanR cassette and thus converted to CamR, was constructed from K11607 using a plasmid, pJLTnpRhygro, which supplied the TnpR resolvase.
Overnight cultures were diluted and grown to early log phase in LB. The cultures were divided into two aliquots; one grown untreated and the other treated with 2 µg/ml mitomycin. Cultures were grown for 3–4 hours, based on time of lysis for the mitomycin C treated culture. Uninduced cultures were diluted every 30 minutes to maintain them in logarithmic growth. Cultures were sonicated 3× for 10 seconds at amplitude of 30% to obtain total cell lysis. Lysates were passed through 0.22 µm filter and concentrated using Amicon Ultra-4 (Millipore). Stx2A levels in supernatants were measured using an enzyme-linked immunoabsorbent assay (ELISA) following a previously published procedure  using anti-Stx2A monoclonal and anti-Stx2 polyclonal antisera. Results were determined as ng Stx2A/µg total protein.
Germ-free Swiss-Webster mice of both sexes were raised in the University of Michigan Laboratory of Animal Medicine germ free colony, housed in soft-sided bubble isolators, and fed autoclaved water and laboratory chow ad libitum. Inoculations, monitoring of animals, and sample collections were performed as previously described . In brief, mice were inoculated orally with ~106 cfu of LB-cultured bacteria. Each group of inoculated animals contained 3 male and 3 female mice between 5 and 6 weeks of age. Throughout the experiment and at necropsy, feces or cecal contents were collected for quantitative EHEC culture. Gram stain and aerobic and anaerobic culture were used to demonstrate the absence of microorganisms other than EHEC. Mice remained sterile (except for the infecting EHEC strain) throughout the course of the experiment.
Mice inoculated with EDL933Δstx:cat or EDL933cIind1 showed no signs of disease and were euthanized 3 weeks after inoculation. All of the mice inoculated with EDL933 became moribund prior to the scheduled necropsy date, and these mice were necropsied when they became moribund, between 10 and 18 days after inoculation (see Results). All animal experiments were conducted with the approval of the University of Michigan Animal Care and Use Committee.
At necropsy, cecal contents were cultured to determine bacterial colonization density. Quantitative counts were determined using LB agar plates containing appropriate antibiotics. Stx concentration in cecal contents was measured using a commercial kit (Premier) as previously described . For histologic examination, right and left kidney were immersion-fixed in formalin, embedded in paraffin, cut in 5 micron sections, and stained with hematoxylin and eosin (Fig. 4). Kidney sections were scored by a single pathologist without knowledge of the source of the section. For quantitation, a midline section of the right renal cortex was examined in its entirety, and the number of 200× fields with tubular or glomerular lesions was recorded. Acute tubular necrosis was subjectively scored as mild, moderate, or severe.
For the SIVET experiment, animals were similarly infected with ~106 cfu of LB-cultured bacteria. Because of the deletion-substitutions in the 933W prophage, the SIVET strain does not express significant levels of Stx2. Details of the experiment procedure have been discussed above. In these experiments colony counts were obtained using LB plates containing either kanamycin (30 µg/ml) or cloramphenicol (9 µg/ml).
Statistics: Quantitative data were analyzed by Mann-Whitney U test. Multiple groups were compared by ANOVA and Fisher's Least Significant Difference.
Construction of EDL933 SIVET strain
The design of SIVET  is based on Camilli and colleague's “Recombinase-based Reporter of Transcription (RIVET) system” , . However, SIVET differs from RIVET in providing a selection for cells in which the assayed transcription occurred (Fig. 1-II). The first generation of EDL933 SIVET, was constructed similarly to the original K12 SIVET strain ,  using recombineering , with a SpcR (this laboratory) derivative of pKD46  supplying the λ Red functions. The 933W prophage was inactivated by elimination of genes controlling two critical components of phage growth, transcription and replication. The N gene, encoding a transcription regulator, was deleted and replaced with a KanR cassette. The O and P genes, encoding proteins involved in initiation of DNA replication , were replaced with the tnpR gene and ampR cassette. This was accomplished using a PCR product containing the ampR cassette and the sequence encoding the 168 variation of the γδ resolvase, tnpR-168,  with flanking sequences having homology to the 933W cro and ren genes (Fig. 1-I). These changes generated strain K11084 that, even though having a defective 933W prophage, is unable to survive treatment with an inducing concentration of mitomycin C. The cryptic prophage CP933V in EDL933, although defective, has nearly a complete lambdoid phage genome , leading us to suspect that its induction might be responsible for this sensitivity to mitomycin C. Therefore, we deleted the control region of CP933V rendering that prophage uninducible; the deletion included the putative repressor (cI) gene with immediate surrounding putative promoters, operators, genes, and relevant associated genetic material in a two-step process. A cat-sacB (CSB) cassette  with flanking ends having appropriate homologies to CP933V (primers 3 and 4, template K9685) was recombined into the targeted region, extending from N to cII (Fig. 1-I) in CP933V, generating strain K11114. The CSB inserted in CP933V was then replaced with a single-stranded DNA oligomer (oligo #1) , generating strain K11115. This strain survives the inducing levels of mitomycin C used in our studies.
Addition of the reporter cassette in a two-step procedure completed the construction of the EDL933 SIVET strain. First, K11161 was constructed by crossing a cat cassette (primers: 9 and 10, K10373 template) into the lacZ gene of K11115 providing homology for the next step. Second, K11173 was constructed by crossing the cat::resC-tetR-resC::cat cassette (primers7 and 8, K10449 template) into the inserted cat gene in K11161 with selection for tetracycline resistance.
This first EDL933 SIVET construct had to be modified because its constitutive expression of TetR made the bacteria sensitive to the in vivo environment. We therefore made the following changes using recombineering, λ Red functions were supplied by a hygromycin resistant derivative of pKD46 (pKD46hygR). The KanR cassette in the N gene was replaced by a spcR cassette and the selective tetR cassette in the cat::resC::tet::resC::cat reporter was replaced by a kanR cassette yielding the cat::resC-kan-resC::cat reporter. To complete the process, the strain was cured of pKD46hygR yielding K11604, the SIVET strain used in the experiments reported here.
Mitomycin C induction
The method used to obtain the results shown in figure 5 was essentially those outlined in Livny and Friedman . Briefly, SIVET strain was grown ~108/ml in LB, made 2 µg/ml in mitomycin C, grown for 2 hrs, washed and resuspended in LB, grown for 4 hours, and dilutions of bacteria were plated on selective media.
This metric provides a log10 scale readout that allows for a simplified comparison of results of different SIVET experiments. The calculations compare the ratio of CamR/KanR colonies at any given time relative to the starting ratio of CamR/KanR colonies. It is calculated as log10 [(CamR titer/KanR titer at any time after start of experiment)/(CamR titer/KanR titer at start of experiment)]. It follows that the Induction Index at the start would obviously be 0; i.e., log10 1 (starting ratio/starting ratio).
Effect of induction of cIind1 mutant on lysis
Overnight cultures of O157:H7 and the cIind1 derivative grown in LB broth were diluted 1:100 in LB and grown to early log phase. Each were divided into two aliquots, one untreated and the other treated with 2 µg/ml of mitomycin C. Samples, 200 µl, were placed in a 96 well plate and grown at 37° with OD600 read at 30 minute intervals in the SpectraMax 250 (Micro Devices).
Mathematical modeling of Induction Index. To determine what would be expected if the contribution to the CamR population by spontaneous induction during growth of the SIVET population were unimpeded, we used mathematical modeling to predict what such an unimpeded expansion would look like. The change in the ratio of CamR/KanR, due to spontaneous induction during bacterial growth is calculated and displayed as an Induction Index over a range of population doublings reaching 1000. This allows comparison with the results obtained by experimentation. The CamR bacteria resulting from the conversion of KanR bacteria are added to the growing CamR culture which is determined by the standard exponential growth equation taking into consideration, as we have shown, that the two populations grow at the same rate. The model is further expanded to take into account possible effects of phenotypic lag, the period following induction needed for the newly converted CamR bacteria to recover from the damage inflicted during the resulting SOS response. The top line shows the expected increase in the ratio CamR/KanR populations due to spontaneous induction, assuming the conversion was free of any factors impeding the conversion number (see text for detailed discussion of possible factors). The lines below show a range of possible delays due to phenotypic lag prior to the first doubling. The starting ratio is set to 1, or an Induction Index of 0 on the log scale. Other factors possibly reducing the actual conversion number were not considered in the modeling.
Supplementary methods. Experimental procedures describing the mathematical modeling of Induction Index.
The authors thank John Little for identification of the Lys codon changed to construct the cIind mutant and valuable discussion. Victor DiRita and N. Cary Engleberg are thanked for helpful suggestions in preparation of the manuscript. Celeste Thorpe and David Acheson are thanked for anti-Stx2 serum. Celeste Thorpe is thanked for purified Stx2. An anonymous reviewer is recognized for pointing out that constitutive expression of TetR could make SIVET sensitive to the in vivo environment. Simione Marino is thanked for help with calculation. We thank Sara Poe and Chriss Vowles for the germ free mouse studies, and Sara Smith for developing the in vivo Stx ELISA.
Conceived and designed the experiments: DIF CJA KAE JHF JST KB. Performed the experiments: DIF CJA JST KB KGS KAE JLR. Analyzed the data: DIF KAE. Contributed reagents/materials/analysis tools: JST DIF JHF. Wrote the paper: DIF.
- 1. Melton-Celsa A, Mohawk K, Teel L, O'Brien AD (2012) Pathogenesis of shiga-toxin producing Escherichia coli. In: Mantis NJ, editor. Ricin and Shiga Toxins Berlin, Germany: Springer-Verlag. pp. 67–103.
- 2. Kaper JB (1998) Enterhemorrhagic Escherichia coli. Curr Opin Microbiol 1: 103–108.
- 3. Muniesa M, Hammerl JA, Hertwig S, Appel B, Brussow H (2012) Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol 78: 4065–4073. doi: 10.1128/aem.00217-12
- 4. Tyler JS, Livny J, Friedman DI (2005) Lambdoid Phages and Shiga Toxin. In: Waldor MK, Friedman DI, Adhya SL, editors. Phages; Their role in Pathogenesis and Biotechnology. Washington, D.C.: ASM Press. pp. 131–164.
- 5. O'Brien AD, Tesh VL, Donohue-Rolfe A, Jackson MP, Olsnes S, et al. (1992) Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 180: 65–94. doi: 10.1007/978-3-642-77238-2_4
- 6. Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073–1086. doi: 10.1016/s0140-6736(05)71144-2
- 7. Eaton KA, Friedman DI, Francis GJ, Tyler JS, Young VB, et al. (2008) Pathogenesis of Renal Disease Due to Enterohemorrhagic Escherichia coli in Germ-Free Mice. Infect Immun 76: 3054–3063. doi: 10.1128/iai.01626-07
- 8. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT (1986) Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163: 1391–1404. doi: 10.1084/jem.163.6.1391
- 9. Sandvig K, Grimmer S, Lauvrak SU, Torgersen ML, Skretting G, et al. (2002) Pathways followed by ricin and Shiga toxin into cells. Histochem Cell Biol 117: 131–141. doi: 10.1007/s00418-001-0346-2
- 10. Reisbig R, Olsnes S, Eiklid K (1981) The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60S ribosomal subunit. J Biol Chem 256: 8739–8744.
- 11. Campbell A (1994) Comparative molecular biology of lambdoid phages. Ann Rev Microbiol 48: 193–222. doi: 10.1146/annurev.mi.48.100194.001205
- 12. Degnan PH, Michalowski CB, Babic AC, Cordes MH, Little JW (2007) Conservation and diversity in the immunity regions of wild phages with the immunity specificity of phage lambda. Mol Microbiol 64: 232–244. doi: 10.1111/j.1365-2958.2007.05650.x
- 13. Botstein D (1980) A theory of modular evolution for bacteriophages. Annals of the New York Academy of Sciences 354: 484–490. doi: 10.1111/j.1749-6632.1980.tb27987.x
- 14. Neely MN, Friedman DI (1998) Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 28: 1255–1267. doi: 10.1046/j.1365-2958.1998.00890.x
- 15. Roberts JW (1993) RNA and protein elements of E. coli and lambda transcription antitermination complexes. Cell 72: 653–655. doi: 10.1016/0092-8674(93)90394-6
- 16. Waldor MK, Friedman DI (2005) Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol 8: 459–465. doi: 10.1016/j.mib.2005.06.001
- 17. Plunkett G 3rd, Rose DJ, Durfee TJ, Blattner FR (1999) Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J Bacteriol 181: 1767–1778.
- 18. Wagner PL, Neely MN, Zhang X, Acheson DW, Waldor MK, et al. (2001) Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol 183: 2081–2085. doi: 10.1128/jb.183.6.2081-2085.2001
- 19. Tyler JS, Mills MJ, Friedman DI (2004) The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression. J Bacteriol 186: 7670–7679. doi: 10.1128/jb.186.22.7670-7679.2004
- 20. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, et al. (2000) Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181: 664–670. doi: 10.1086/315239
- 21. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342: 1930–1936. doi: 10.1056/nejm200006293422601
- 22. Friedman DI, Court DL (2001) Bacteriophage lambda: alive and well and still doing its thing. Curr Opin Microbiol 4: 201–207. doi: 10.1016/s1369-5274(00)00189-2
- 23. Little JW (1996) The SOS Regulatory System. In: Lin ECC, Lynch AS, editors. Regulation of Gene Expression in Escherichia coli. Austin TX: R.G. Landes. pp. 453–479.
- 24. Sutton MD, Smith BT, Godoy VG, Walker GC (2000) The SOS response: recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Annu Rev Genet 34: 479–497. doi: 10.1146/annurev.genet.34.1.479
- 25. Little JW (2005) Lysogeny, prophage induction, and lysogenic conversion. In: Waldor MK, Friedman DI, Adhya SL, editors. Phages: Their role in bacterial pathogenesis and biotechnology. Washington, D.C.: ASM Press. pp. 37–54.
- 26. Friedman DI, Court DL (2006) Regulation of lambda gene expression by transcription termination and antitermination. In: Calendar R, editor. The Bacteriophages. Oxford: Oxford Press. pp. 83–103.
- 27. Roberts JW, Yarnell W, Bartlett E, Guo J, Marr M, et al. (1998) Antitermination by bacteriophage lambda Q protein. Cold Spring Harb Symp Quant Biol LXIII: 319–325. doi: 10.1101/sqb.1998.63.319
- 28. Karch H, Schmidt H, Janetzki-Mittmann C, Scheef J, Kroger M (1999) Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages. Mol Gen Genet 262: 600–607. doi: 10.1007/s004380051122
- 29. Roberts JW, Devoret R (1983) Lysogenic Induction. In: Hendrix RW, Roberts JW, Stahl FW, Weisberg RA, editors. Lambda II. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. pp. 123–144.
- 30. Gimble FS, Sauer RT (1985) Mutations in bacteriophage lambda repressor that prevent RecA-mediated cleavage. J Bacteriol 162: 147–154.
- 31. Little JW (2006) Gene regulatory circuitry of phage lambda. In: Calendar R, editor. The Bacteriophages. New York, New York: Oxford University Press. pp. 74–82.
- 32. Little JW (1984) Autodigestion of lexA and phage lambda repressors. Proc Natl Acad Sci USA 81: 1375–1379. doi: 10.1073/pnas.81.5.1375
- 33. Fuchs S, Muhldorfer I, Donohue-Rolfe A, Kerenyi M, Emody L, et al. (1999) Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Micro Path 27: 13–23. doi: 10.1006/mpat.1999.0279
- 34. Clark AJ (1973) Recombination deficient mutants of E. coli and other bacteria. Annu Rev Genet 7: 67–86. doi: 10.1146/annurev.ge.07.120173.000435
- 35. Little JW, Mount DW (1982) The SOS regulatory system of Escherichia coli. Cell 29: 11–22. doi: 10.1016/0092-8674(82)90085-x
- 36. Wagner PL, Acheson DW, Waldor MK (2001) Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun 69: 1934–1937. doi: 10.1128/iai.69.3.1934-1937.2001
- 37. Slilaty SN, Little JW (1987) Lysine-156 and serine-119 are required for LexA repressor cleavage: a possible mechanism. Proc Natl Acad Sci USA 84: 3987–3991. doi: 10.1073/pnas.84.12.3987
- 38. Lin LL, Little JW (1988) Isolation and characterization of noncleavable (Ind-) mutants of the LexA repressor of Escherichia coli K-12. J Bacteriol 170: 2163–2173.
- 39. Iyer VN, Szybalski W (1963) A Molecular Mechanism of Mitomycin Action: Linking of Complementary DNA Strands. Proc Natl Acad Sci U S A 50: 355–362. doi: 10.1073/pnas.50.2.355
- 40. Otsuji N, Sekiguchi M, Iijima T, Takagi Y (1959) Induction of phage formation in the lysogenic Escherichia coli K-12 by mitomycin C. Nature 184: 1079–1080. doi: 10.1038/1841079b0
- 41. Perna NT, Plunkett Gr, Burland V, Mau B, Glasner JD, et al. (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409: 529–533. doi: 10.1038/35054089
- 42. Casadaban MJ, Cohen SN (1980) Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol 138: 179–207. doi: 10.1016/0022-2836(80)90283-1
- 43. Isogai E, Isogai H, Hayashi S, Kubota T, Kimura K, et al. (2000) Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection. Microbiol Immunol 44: 89–95. doi: 10.1111/j.1348-0421.2000.tb01251.x
- 44. Herold S, Siebert J, Huber A, Schmidt H (2005) Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin. Antimicrob Agents Chemother 49: 931–944. doi: 10.1128/aac.49.3.931-944.2005
- 45. Camilli A, Beattie DT, Mekalanos JJ (1994) Use of genetic recombination as a reporter of gene expression. Proc Natl Acad Sci USA 91: 2634–2638. doi: 10.1073/pnas.91.7.2634
- 46. Lee SH, Hava DL, Waldor MK, Camilli A (1999) Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99: 625–634. doi: 10.1016/s0092-8674(00)81551-2
- 47. Livny J, Friedman DI (2004) Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol Microbiol 51: 1691–1704. doi: 10.1111/j.1365-2958.2003.03934.x
- 48. Eisen HA, Fuerst CR, Siminovitch L, Thomas R, Lambert L, et al. (1966) Genetics and physiology of defective lysogeny in K12 (λ): studies of early mutants. Virology 30: 224–241. doi: 10.1016/0042-6822(66)90098-5
- 49. Grindley ND (1983) Transposition of Tn3 and related transposons. Cell 32: 3–5. doi: 10.1016/0092-8674(83)90490-7
- 50. Waldor MK, Friedman DI, Adhya SL (2005) Phages; Their role in bacterial pathogenesis and biotechnology. Washington, D.C.: ASM Press.
- 51. Brussow H, Canchaya C, Hardt WD (2004) Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68: 560–602. doi: 10.1128/mmbr.68.3.560-602.2004
- 52. Johnson EA (2005) Bacteriophages encoding botulism and diphtheria toxins. In: Waldor MK, Friedman DI, Adhya SL, editors. Phage; Their Role in Bacterial Pathogenesis and Biotechnology. Washington, D.C.: ASM Press.
- 53. Waldor MK, Mekalanos JJ (1996) Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272: 1910–1914. doi: 10.1126/science.272.5270.1910
- 54. Matson JS, Withey JH, DiRita VJ (2007) Regulatory networks controlling Vibrio cholerae virulence gene expression. Infect Immun 75: 5542–5549. doi: 10.1128/iai.01094-07
- 55. Frost LS, Leplae R, Summers AO, Toussaint A (2005) Mobile genetic elements: the agents of open source evolution. Nat Rev Microbiol 3: 722–732. doi: 10.1038/nrmicro1235
- 56. Robinson CM, Sinclair JF, Smith MJ, O'Brien AD (2006) Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A 103: 9667–9672. doi: 10.1073/pnas.0602359103
- 57. Broudy TB, Pancholi V, Fischetti VA (2001) Induction of lysogenic bacteriophage and phage-associated toxin from group A Streptococci during coculture with human pharyngeal cells. Infect Immun 69: 1440–1443. doi: 10.1128/iai.69.3.1440-1443.2001
- 58. de Sablet T, Chassard C, Bernalier-Donadille A, Vareille M, Gobert AP, et al. (2009) Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 77: 783–790. doi: 10.1128/iai.01048-08
- 59. Khalil AS, Collins JJ (2010) Synthetic biology: applications come of age. Nat Rev Genet 11: 367–379. doi: 10.1038/nrg2775
- 60. Friedman N, Vardi S, Ronen M, Alon U, Stavans J (2005) Precise temporal modulation in the response of the SOS DNA repair network in individual bacteria. PLoS Biol 3: e238. doi: 10.1371/journal.pbio.0030238
- 61. Little JW (1983) The SOS regulatory system: control of its state by the level of RecA protease. J Mol Biol 167: 791–808. doi: 10.1016/s0022-2836(83)80111-9
- 62. Sawitzke JA, Costantino N, Li XT, Thomason LC, Bubunenko M, et al. (2011) Probing cellular processes with oligo-mediated recombination and using the knowledge gained to optimize recombineering. J Mol Biol 407: 45–59. doi: 10.1016/j.jmb.2011.01.030
- 63. Court DL, Sawitzke JA, Thomason LC (2002) Genetic engineering using homologous recombination. Annu Rev Genet 36: 361–388. doi: 10.1146/annurev.genet.36.061102.093104
- 64. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG, et al. (2000) An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci USA 97: 5978–5983. doi: 10.1073/pnas.100127597
- 65. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640–6645. doi: 10.1073/pnas.120163297
- 66. Lahue RS, Au KG, Modrich P (1989) DNA mismatch correction in a defined system. Science 245: 160–164. doi: 10.1126/science.2665076
- 67. Costantino N, Court DL (2003) Enhanced levels of lambda Red-mediated recombinants in mismatch repair mutants. Proc Natl Acad Sci U S A 100: 15748–15753. doi: 10.1073/pnas.2434959100
- 68. Murphy KC, Campellone KG (2003) Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol 4: 11.
- 69. Wagner PL, Livny J, Neely MN, Acheson DW, Friedman DI, et al. (2002) Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 44: 957–970. doi: 10.1046/j.1365-2958.2002.02950.x
- 70. Livny J, LaRock CN, Friedman DI (2009) Identification and isolation of lysogens with induced prophage. In: Cloakie MRJ, Kropinski AM, editors. Bacteriophages, Methods and Protocls. New York, NY: Humana Press. pp. 253–265.
- 71. Ellis HM, Yu D, DiTizio T, Court DL (2001) High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides. Proc Natl Acad Sci USA 98: 6742–6746. doi: 10.1073/pnas.121164898
- 72. Gottesman ME, Yarmolinsky MB (1968) Integration-negative Mutants of Bacteriophage Lambda. J Mol Biol 31: 487–505. doi: 10.1016/0022-2836(68)90423-3
- 73. Datta S, Costantino N, Court DL (2006) A set of recombineering plasmids for gram-negative bacteria. Gene 379: 109–115. doi: 10.1016/j.gene.2006.04.018
- 74. O'Brien AD, Newland JW, Miller SF, Holmes RK, Smith HW, et al. (1984) Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226: 694–696. doi: 10.1126/science.6387911
- 75. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, et al. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681–685. doi: 10.1056/nejm198303243081203
- 76. Livny J (2003) Characterizing the role of the lambdoid prophage H-19B in the production and release of Shiga toxin. Ann Arbor, Michigan: Ph.D. Thesis, University of Michigan.